Allocation of Non-Commercial CAB for PrEP Supply in Low- and Middle-Income Countries, 2023-2025

Malaysia, Nigeria, Peru, Zambia, and the European Medicines Agency have approved CAB for PrEP; ViiV also made submissions in Canada, Colombia, and the United Kingdom. There are now 13 regulatory approvals and 15 additional submissions that are pending.

HIV Vaccine and Antibody Efficacy Trials to Date

This infographic provides a comprehensive overview of HIV vaccine and antibody efficacy trials. Over 20 years and 12 trials, only two positive signals have been observed.

Cumulative PrEP Initiations

2016-2025

In 2020, the world missed the UNAIDS’ goal of reaching 3 million PrEP users. The updated target for 2025 is 10 million. Is the 2025 target achievable based on the current trends in PrEP uptake? Excerpted from an issue of PxWire.

STI Diagnostic R&D Funding by Pathogen

This bar chart shows STI diagnostic research & development funding by pathogen.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine R&D Funding by Pathogen

This bar chart shows STI vaccine R&D funding by pathogen.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding among US and International Organizations

This pie chart shows STI vaccine and diagnostic R&D funding among US and international organizations.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Research Funding: Top 20 Institutions and Organizations

This chart lists the top twenty organizations funding STI diagnostic and vaccine research.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Research Funding Distribution by Country of Institution

This map shows the funding distribution of STI vaccine and diagnostic funding by country of institution.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by NIH IC and Topic

This chart shows STI vaccine and diagnostic R&D funding by NIH institutes and centers and by topic.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.

STI Vaccine and Diagnostic R&D Funding by NIH IC

This pie chart provides a breakdown research & development funding for STI vaccines and diagnostics by NIH institutes and centers.

Excerpted from STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments, the full report is available at stiwatch.org/resource-tracking.